Trial Details
AuthorisedBasic Information
| Clinical ID | c2236 |
|---|---|
| Identifier | EUCTR2022-002648-35-NL |
| Trial Title | Prospective Analysis of Pharmacokinetic Infliximab Data in pediatric CD_patients - PRO-RAPID |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Crohn's disease;Therapeutic area: Diseases [C] - Immune System Diseases [C20] |
| Interventions | Product Name: Infliximab Pharmaceutical Form: Powder for concentrate for solution for infusion |
Participant Information
| Sponsor | Erasmus Medical Center |
|---|---|
| City | - |
| Country/Region | Netherlands;Italy |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |